Scientists Develop First CRISPR-Based Drug Targeting Microbiome
Many people have experienced infections from E. coli, which are primarily seen as inconvenient and unpleasant. For some patients, like those with
Many people have experienced infections from E. coli, which are primarily seen as inconvenient and unpleasant. For some patients, like those with